influenza
virus
caus
acut
highli
contagi
season
respiratori
diseas
age
group
million
case
sever
influenzarel
ill
death
report
everi
year
addit
constant
season
outbreak
highli
pathogen
avian
influenza
hpai
strain
remain
ongo
pandem
threat
recent
figur
show
confirm
laboratori
infect
mortal
rate
import
note
human
littl
preexist
immun
toward
avian
influenza
viru
strain
moreov
commerci
avail
human
vaccin
given
potenti
virus
trigger
urgent
need
develop
novel
therapeut
intervent
combat
known
defici
abil
control
outbreak
current
season
influenza
viru
prophylact
therapeut
strategi
involv
use
vaccin
antivir
vaccin
efficaci
highli
variabl
evidenc
particularli
sever
epidem
frequent
reformul
vaccin
requir
combat
ongo
mutat
influenza
viru
genom
addit
antivir
resist
report
mani
circul
strain
includ
avian
influenza
viru
emerg
influenza
virus
also
shown
target
hijack
multipl
host
cellular
pathway
promot
surviv
increas
evid
suggest
target
host
pathway
influenc
viru
replic
inflamm
immun
altern
intervent
strategi
base
modul
host
respons
could
use
supplement
current
prophylact
therapeut
protocol
impact
influenza
viru
infect
rel
well
studi
anim
human
cellular
respons
poorli
defin
due
lack
avail
human
autopsi
materi
especi
hpai
virusinfect
patient
present
studi
character
influenza
viru
infect
primari
human
alveolar
epitheli
type
ii
atii
cell
isol
normal
human
lung
tissu
donat
patient
undergo
lung
resect
atii
cell
physiolog
relev
infect
model
main
target
influenza
virus
enter
respiratori
human
host
gene
express
follow
hpai
viru
infect
primari
atii
cell
analyz
use
illumina
hiseq
deep
sequenc
order
gain
better
understand
mechan
underli
modul
host
immun
antiinflammatori
environ
also
analyz
chang
gene
express
follow
hpai
infect
presenc
reactiv
oxygen
speci
ro
inhibitor
apocynin
compound
known
interfer
nadph
oxidas
subunit
hiseq
analysi
describ
herein
focus
differenti
regul
gene
follow
infect
sever
criteria
consid
choos
hit
studi
includ
novelti
gene
studi
context
influenza
viru
infectionpathogenesi
immunoregul
gene
regulatori
role
host
immun
respons
potenti
manipul
improv
immun
therapeut
reagent
exist
commerci
avail
therapeut
reagent
specif
inhibitor
inhibitori
antibodi
util
vitro
vivo
studi
order
optim
therapeut
strategi
anim
model
knockout
mous
model
avail
vivo
influenza
infect
studi
base
criteria
carcinoembryonicantigen
cea
relat
cell
adhes
molecul
chosen
key
gene
interest
also
known
bgp
express
epitheli
endotheli
well
b
cell
cell
neutrophil
nk
cell
macrophag
dendrit
cell
dc
human
shown
act
receptor
sever
human
bacteri
fungal
pathogen
includ
haemophilu
influenza
escherichia
coli
salmonella
typhi
candida
albican
yet
implic
viru
howev
emerg
evid
suggest
involv
host
immun
enhanc
express
lymphocyt
detect
pregnant
women
infect
cervic
tissu
isol
patient
papillomaviru
eleven
splice
variant
report
isoform
uniprot
differ
number
immunoglobulinlik
domain
present
presenc
absenc
transmembran
domain
andor
length
cytoplasm
tail
ie
l
long
short
fulllength
human
protein
consist
four
extracellular
domain
one
extracellular
immunoglobulin
variableregionlik
igvlik
domain
three
immunoglobulin
constant
region
domain
transmembran
domain
long
l
cytoplasm
tail
long
cytoplasm
tail
contain
two
immunoreceptor
tyrosinebas
inhibitori
motif
itim
absent
short
common
isoform
express
human
immun
cell
interact
homophil
heterophil
relat
ceacam
famili
member
dimer
state
allow
recruit
signal
molecul
srcfamili
kinas
includ
tyrosin
phosphatas
src
homolog
domain
contain
protein
tyrosin
phosphatas
member
phosphoryl
presenc
absenc
itim
isoform
influenc
signal
properti
downstream
cellular
function
homophil
heterophil
interact
itim
phosphoryl
critic
mani
biolog
process
includ
regul
lymphocyt
function
immunosurveil
cell
growth
neutrophil
activ
adhes
target
cell
inflammatori
note
express
modul
vivo
use
antibodi
inhibit
melanoma
xenograft
growth
scidnod
block
homophil
interact
inhibit
cell
effector
function
enhanc
kill
melanoma
cell
highlight
potenti
intervent
pathway
exploit
diseas
process
includ
viru
infect
addit
mice
avail
vivo
infect
studi
result
show
mrna
protein
express
level
highli
elev
follow
hpai
infect
furthermor
small
interf
rna
sirna
mediat
inhibit
reduc
inflammatori
cytokin
chemokin
product
importantli
inhibit
viru
replic
primari
human
atii
cell
continu
human
type
ii
respiratori
epitheli
cell
line
taken
togeth
observ
suggest
attract
candid
modul
influenzaspecif
immun
summari
studi
identifi
novel
target
may
influenc
hpai
immun
serv
highlight
import
manipul
host
respons
way
improv
diseas
outcom
context
viru
infect
atii
cell
isol
human
infect
apic
side
multipl
infect
moi
hour
rna
extract
hiseq
perform
sampl
read
map
human
genom
assembl
transcriptom
differenti
express
analysi
total
gene
identifi
fpkm
fragment
per
kilobas
exon
per
million
fragment
map
least
one
three
experiment
group
total
gene
significantli
upregul
gene
significantli
downregul
q
valu
chang
follow
infect
nd
vs
hd
fig
tabl
hpai
infect
atii
cell
activ
antivir
state
evidenc
upregul
numer
interferoninduc
gene
gene
associ
pathogen
defens
cell
prolifer
apoptosi
metabol
tabl
tabl
addit
kyoto
encyclopedia
gene
genom
kegg
pathway
map
show
mani
upregul
gene
hd
group
map
tnf
signal
tolllik
receptor
signal
cytokinecytokin
receptor
interact
rigilik
receptor
signal
tabl
tabl
apocynintr
ha
group
larg
number
gene
also
significantli
upregul
gene
downregul
gene
fig
tabl
rel
nd
control
group
whilst
subset
gene
differenti
express
hd
ha
group
either
upregul
gene
fig
downregul
gene
fig
major
gene
fact
overlap
hd
ha
group
fig
e
suggest
apocynin
treatment
affect
gene
express
independ
infect
gene
ontolog
go
enrich
analysi
gene
upregul
apocynin
show
involv
type
interferon
signal
pathway
defens
respons
viru
neg
regul
viral
process
respons
stress
tabl
nd
vs
ha
gene
downregul
apocynin
includ
involv
cell
adhes
regul
cell
migrat
regul
cell
prolifer
signal
transduct
oxidationreduct
process
tabl
nd
vs
ha
total
gene
upregul
follow
infect
nd
vs
hd
fig
overlap
two
list
gene
nd
vs
hd
hd
vs
ha
gene
shown
downregul
presenc
apocynin
fig
overlap
three
list
gene
nd
vs
hd
hd
vs
ha
nd
vs
ha
gene
gene
plu
gene
present
three
list
fig
indic
gene
significantli
inhibit
apocynin
level
still
significantli
higher
uninfect
cell
gene
includ
involv
influenza
immun
pml
jakstat
signal
rigilik
receptor
signal
antigen
process
present
hladob
tabl
therefor
critic
immun
respons
induc
follow
infect
dampen
follow
apocynin
treatment
remain
gene
present
nd
vs
ha
list
suggest
gene
significantli
inhibit
apocynin
level
similar
uninfect
control
cell
fig
gene
includ
involv
tnf
signal
cflar
vegfc
cytokinecytokin
receptor
interact
vegfc
nfkappa
b
signal
pathway
cflar
signal
myc
vegfc
tabl
consist
role
apocynin
reduc
overlap
three
list
gene
nd
vs
hd
hd
vs
ha
nd
vs
ha
gene
found
three
comparison
fig
suggest
gene
upregul
follow
infect
significantli
reduc
apocynin
treatment
level
lower
observ
uninfect
control
cell
fig
among
inflammatori
cytokineschemokin
gene
includ
axl
member
tam
receptor
famili
receptor
tyrosin
kinas
stimul
ifn
gene
tabl
previou
studi
demonstr
infect
cell
presenc
apocynin
enhanc
express
neg
regul
cytokin
signal
soc
turn
result
reduct
cytokin
chemokin
product
cell
attribut
lower
viru
replic
viru
titer
affect
apocynin
perform
qrtpcr
analysi
rna
sampl
submit
hiseq
analysi
valid
hiseq
result
fig
fig
fig
fig
gene
express
significantli
elev
atii
cell
follow
infect
reduc
addit
apocynin
except
consist
previou
find
infect
alon
induc
express
shown
hiseq
qrtpcr
analysi
fig
apocynin
treatment
increas
mrna
express
fig
although
hiseq
analysi
detect
statist
signific
increas
follow
apocynin
treatment
foldchang
gene
express
similar
hd
ha
group
vs
fig
hiseq
analysi
transcript
show
signific
increas
follow
infect
apocynin
treatment
fig
qrtpcr
analysi
show
although
mrna
slightli
increas
follow
infect
significantli
upregul
presenc
apocynin
fig
therefor
apocynin
also
contribut
reduct
cytokin
chemokin
product
atii
cell
apocynin
compound
inhibit
product
ro
shown
influenc
influenzaspecif
respons
although
viru
titer
affect
apocynin
treatment
antivir
activ
observ
vivo
mice
infect
low
pathogen
hiseq
analysi
hpai
viru
gene
transcript
show
although
trend
increas
influenza
viru
gene
express
follow
apocynin
treatment
influenza
nonstructur
ns
gene
express
significantli
increas
fig
reduc
cytokin
chemokin
product
atii
cell
fig
unlik
associ
lower
viru
replic
go
enrich
analysi
perform
gene
significantli
upregul
follow
hpai
infect
atii
cell
presenc
absenc
apocynin
identifi
overpres
go
term
mani
gene
broadli
involv
defens
respons
respons
extern
biotic
stimulu
immun
system
process
cytokinemedi
signal
pathway
type
interferon
signal
pathway
tabl
tabl
addit
mani
gene
map
metabol
pathway
cytokinecytokin
receptor
interact
influenza
tnf
signal
jakstat
signal
tabl
howev
gene
pathway
inhibit
apocynin
treatment
mention
fig
tabl
cell
adhes
molecul
shown
critic
regul
immun
respons
infect
inflamm
transcript
significantli
upregul
follow
infect
fig
contrast
relat
member
ceacam
famili
affect
infect
fig
also
worth
note
read
obtain
fpkm
fig
fpkm
fig
uninfect
atii
cell
consist
normal
express
pattern
human
lung
therefor
although
form
heterodim
higher
basal
express
atii
cell
may
explain
express
enhanc
infect
endogen
protein
express
also
analyz
uninfect
influenza
virusinfect
fig
atii
cell
fig
protein
express
slightli
significantli
increas
cell
infect
apuerto
viru
hour
compar
uninfect
cell
fig
signific
differ
protein
level
observ
variou
moi
hpi
timepoint
fig
exam
protein
express
follow
infect
viru
cell
protein
express
examin
primari
human
atii
cell
infect
hpai
compar
viru
infect
fig
atii
cell
infect
viru
moi
dose
induc
upregul
cytokin
influenza
matrix
gene
analyz
qrtpcr
data
shown
lower
moi
hpai
test
due
strong
cytopathogen
effect
caus
higher
moi
endogen
protein
level
significantli
similarli
elev
atii
cell
three
moi
test
protein
express
atii
cell
infect
moi
higher
hpi
observ
hpi
fig
hpai
viru
infect
moi
stimul
higher
endogen
level
protein
express
compar
viru
infect
moi
correspond
time
point
maximum
increas
induc
moi
hpi
compar
moi
suggest
possibl
role
influenza
viru
pathogen
fig
order
understand
role
influenza
pathogenesi
atii
cell
transfect
knockdown
endogen
protein
express
atii
cell
transfect
sineg
neg
control
express
four
main
variant
protein
analyz
use
sybr
green
qrtpcr
western
blot
respect
sybr
green
qrtpcr
analysi
show
atii
cell
transfect
pmol
significantli
reduc
express
compar
sineg
control
express
alter
fig
protein
express
reduc
approxim
atii
cell
follow
transfect
compar
sinegtransfect
cell
fig
increas
dose
pmol
downregul
protein
express
cell
fig
pmol
chosen
subsequ
knockdown
studi
atii
cell
import
note
antibodi
detect
l
isoform
base
epitop
inform
provid
abcam
therefor
observ
reduct
protein
express
attribut
mainli
abolish
function
consequ
knockdown
examin
atii
cell
follow
infect
tnf
product
analyz
atii
cell
use
qrtpcr
atii
fig
cell
fig
transfect
show
significantli
lower
express
compar
sinegtransfect
cell
howev
express
antivir
cytokin
affect
cell
type
addit
tnf
express
induc
type
significantli
lower
cell
fig
affect
atii
cell
fig
hypercytokinemia
cytokin
storm
virusinfect
patient
thought
contribut
inflammatori
tissu
downregul
context
sever
viral
infect
may
reduc
inflamm
caus
infect
without
dampen
antivir
respons
furthermor
viru
replic
significantli
reduc
atii
fig
cell
fig
transfect
compar
sinegtransfect
cell
viru
titer
sinegtransfect
control
cell
significantli
differ
observ
mocktransfect
control
cell
fig
influenza
virus
util
host
cellular
machineri
manipul
normal
cell
process
order
promot
replic
evad
host
immun
respons
studi
field
increasingli
focus
understand
modifi
key
host
factor
order
amelior
diseas
exampl
includ
modul
ro
reduc
inhibit
mitogen
rafmekerk
kinas
cascad
activ
suppress
viral
host
target
strategi
offer
altern
current
intervent
focus
target
viru
present
studi
analyz
human
host
gene
express
profil
follow
hpai
infect
treatment
antioxid
apocynin
expect
gene
significantli
upregul
follow
infect
involv
biolog
process
includ
cytokin
signal
immun
apoptosi
addit
gene
also
involv
regul
protein
phosphoryl
cellular
metabol
cell
prolifer
thought
exploit
virus
apocynin
treatment
antivir
tabl
provir
impact
fig
surpris
ro
potent
microbicid
agent
well
import
immun
signal
molecul
differ
hand
apocynin
treatment
reduc
inflamm
also
impact
cellular
defens
respons
cytokin
product
cytokinemedi
signal
importantli
critic
antivir
respons
compromis
ie
express
pattern
recognit
receptor
eg
rigi
tlr
downregul
tabl
given
signific
interfer
influenza
virus
host
immun
focus
attent
key
regul
immun
respons
hiseq
analysi
identifi
cell
adhes
molecul
critic
regul
immun
knockdown
endogen
inhibit
viru
replic
reduc
inflammatori
cytokinechemokin
product
infect
result
signific
upregul
number
inflammatori
cytokineschemokin
gene
includ
axl
sting
significantli
reduc
apocynin
treatment
level
lower
observ
uninfect
cell
tabl
previous
demonstr
antiaxl
antibodi
treatment
mice
significantli
reduc
lung
inflamm
viru
sting
shown
import
promot
antivir
respons
stingknockout
cell
produc
less
type
ifn
follow
influenza
viru
reduct
sting
gene
express
antivir
factor
eg
tabl
apocynin
may
part
explain
slight
increas
influenza
gene
transcript
follow
apocynin
treatment
fig
result
also
suggest
apocynin
treatment
may
reduc
inflamm
apoptosi
inde
antiinflammatori
antiapoptot
effect
apocynin
shown
previous
number
diseas
model
includ
diabet
myocardi
influenza
viru
recognit
intracellular
viral
rna
pattern
recognit
receptor
prr
trigger
releas
proinflammatori
cytokineschemokin
recruit
innat
immun
cell
neutrophil
nk
cell
site
infect
assist
viral
neutrophil
exert
cytotox
function
first
attach
influenzainfect
epitheli
cell
via
adhes
molecul
moreov
studi
indic
influenza
viru
infect
promot
neutrophil
delay
viru
phosphoryl
itim
motif
activ
critic
mediat
antiapoptot
event
promot
surviv
suggest
antiapoptot
event
may
import
resolut
influenza
viru
infect
vivo
investig
infect
studi
mice
nk
cell
play
critic
role
innat
defens
influenza
virus
recogn
kill
infect
cell
influenza
virus
howev
employ
sever
strategi
escap
nk
effector
function
includ
modif
influenza
hemagglutinin
ha
glycosyl
avoid
nk
activ
receptor
homo
heterophil
interact
shown
inhibit
thought
contribut
tumor
cell
immun
given
find
one
could
suggest
possibl
upregul
inhibit
nk
activ
may
novel
uncharacter
immun
evas
strategi
employ
influenza
virus
laboratori
investig
role
nk
cell
function
smallmolecul
inhibitor
protein
kinas
protein
phosphatas
eg
inhibitor
src
jak
develop
therapi
cancer
inflamm
immun
metabol
modul
phosphoryl
dimer
downstream
function
smallmolecul
inhibitor
may
assist
dissect
contribut
nk
cell
activ
molecular
mechan
action
follow
infect
also
explor
cell
use
vitenshtein
et
al
demonstr
upregul
follow
recognit
viral
rna
rigi
upregul
interferon
regulatori
factor
depend
addit
phosphoryl
inhibit
viral
replic
reduc
phosphoryl
mammalian
target
rapamycin
mtor
suppress
global
cellular
protein
product
present
studi
use
physiolog
relev
infect
model
primari
human
atii
cell
studi
role
influenza
viru
infect
focus
hpai
viru
consist
find
vitenshtein
et
al
signific
upregul
protein
observ
follow
influenza
viru
infect
especi
hpai
cell
howev
contrast
inhibitori
effect
influenza
viru
replic
observ
vitenshtein
et
al
knockdown
endogen
protein
express
reduc
hpai
titer
atii
cell
despit
use
two
differ
vitro
experiment
set
differ
influenza
viru
strain
infect
dose
time
point
studi
agre
play
import
role
influenza
viru
infect
warrant
investig
studi
requir
investigateconfirm
molecular
mechan
upregul
follow
influenza
viru
infect
especi
vivo
upregul
observ
viru
infect
import
determin
whether
common
mechan
action
attribut
order
determin
function
signific
establish
could
use
target
develop
panantivir
agent
summari
molecul
cell
surfac
particularli
attract
candid
therapeut
develop
drug
need
cross
cell
membran
order
effect
target
hostencod
gene
combin
current
antivir
vaccin
may
way
reduc
morbid
mortal
associ
influenza
viru
infect
studi
clearli
demonstr
increas
express
observ
primari
human
atii
cell
infect
hpai
influenza
viru
importantli
knockdown
express
result
reduct
influenza
viru
replic
suggest
target
molecul
may
assist
improv
diseas
outcom
human
nontumor
lung
tissu
sampl
donat
anonym
patient
undergo
lung
resect
univers
hospit
geelong
australia
research
protocol
human
ethic
approv
human
ethic
committe
deakin
univers
barwon
health
commonwealth
scientif
industri
research
organis
csiro
inform
consent
obtain
tissu
donor
research
perform
accord
guidelin
state
nation
statement
ethic
conduct
human
research
sampl
normal
lung
tissu
confirm
victorian
cancer
biobank
australia
lung
specimen
preserv
hartmann
solut
baxter
hour
maintain
cellular
integr
viabil
cell
isol
human
alveolar
epitheli
type
ii
atii
cell
isol
cultur
use
previous
describ
minor
modif
briefli
lung
tissu
visibl
bronchi
remov
perfus
abund
pb
submerg
trypsinedta
gibco
twice
min
partial
digest
tissu
slice
section
digest
hank
balanc
salt
solut
hbss
contain
elastas
unitsml
roch
diagnost
dnase
mgml
roch
diagnost
min
singl
cell
suspens
obtain
filtrat
cell
strainer
cell
includ
macrophag
fibroblast
allow
attach
tissuecultur
treat
petri
dish
mixtur
medium
gibco
small
airway
growth
medium
sagm
medium
lonza
contain
fetal
calf
serum
fc
mgml
dnase
hour
nonadher
cell
includ
atii
cell
collect
subject
centrifug
g
min
discontinu
percol
densiti
gradient
gml
purifi
atii
cell
interfac
two
densiti
gradient
collect
wash
hbss
resuspend
sagm
medium
supplement
charcoalfilt
fc
gibco
unitsml
penicillin
streptomycin
gibco
atii
cell
plate
polyest
transwel
insert
pore
corn
coat
type
iv
human
placenta
collagen
mgml
sigma
cultur
liquidcov
condit
humidifi
incub
growth
medium
chang
everi
hour
cultur
condit
suppress
fibroblast
expans
within
freshli
isol
atii
cell
encourag
atii
cell
form
confluent
monolay
typic
larg
somewhat
squar
increas
express
surfact
protein
c
spc
data
shown
carcinom
human
alveolar
basal
epitheli
type
iilik
cell
madindarbi
canin
kidney
mdck
cell
provid
tissu
cultur
facil
australian
anim
health
laboratori
aahl
csiro
mdck
cell
maintain
ham
medium
gibco
medium
invitrogen
respect
supplement
fc
uml
penicillin
streptomycin
gibco
maintain
hpai
obtain
aahl
csiro
viral
stock
apuerto
obtain
univers
melbourn
viru
stock
prepar
use
standard
inocul
embryon
egg
singl
stock
viru
prepar
use
assay
experi
perform
within
biosafeti
level
laboratori
aahl
csiro
cell
infect
influenza
virus
previous
briefli
cultur
media
remov
cell
wash
warm
pb
three
time
follow
inocul
viru
hour
viru
remov
cell
wash
warm
pb
three
time
incub
appropri
fresh
serumfre
cultur
media
contain
bsa
uninfect
infect
cell
process
ident
hiseq
analysi
atii
cell
three
donor
infect
apic
side
moi
hour
serumfre
sagm
medium
supplement
bovin
serum
albumin
bsa
contain
mm
apocynin
dissolv
dmso
dmso
vehicl
control
uninfect
atii
cell
incub
media
contain
dmso
use
neg
control
subsequ
viru
infect
studi
atii
cell
differ
set
three
donor
differ
use
hiseq
analysi
cell
least
three
differ
passag
infect
influenza
virus
variou
moi
indic
text
studi
follow
transfect
sirna
infecti
dose
optim
moi
dose
significantli
higher
protein
express
induc
minim
cell
death
hpi
infect
studi
final
concentr
chloromethyl
keton
tpck
treat
trypsin
worthington
includ
media
postinocul
assist
replic
viru
titer
determin
use
standard
plaqu
assay
mdck
cell
previous
atii
cell
three
donor
use
hiseq
analysi
total
rna
extract
cell
use
rneasi
mini
kit
qiagen
influenzainfect
cell
wash
pb
three
time
cell
lyse
rlt
buffer
supplement
gibco
cell
lysat
homogen
qiashredd
column
follow
oncolumn
dna
digest
rnasefre
dnase
set
qiagen
rna
extract
accord
manufactur
instruct
initi
qc
conduct
ensur
quantiti
qualiti
rna
sampl
hiseq
analysi
met
follow
criteria
rna
sampl
ratio
measur
nanodroptm
spectrophotomet
thermo
scientif
sampl
concentr
minimum
rna
analyz
agaros
gel
electrophoresi
rna
integr
qualiti
valid
presenc
sharp
clear
band
ribosom
rna
ratio
along
absenc
genom
dna
degrad
rna
part
initi
qc
indic
consist
infect
parallel
quantit
realtim
revers
transcriptas
pcr
qrtpcr
use
rna
sampl
use
hiseq
analysi
perform
duplic
previous
measur
mrna
express
tnf
known
upregul
follow
hpai
infect
rna
sampl
store
volum
sodium
acet
depctreat
water
volum
ethanol
submit
macrogen
inc
seoul
republ
korea
hiseq
analysi
illumina
hiseq
sequenc
system
bp
pairedend
sequenc
confirm
checksum
assess
raw
data
qualiti
fastq
file
fastqc
rnaseq
read
process
accord
standard
tuxedo
pipelin
use
annot
human
genom
download
illumina
igenom
refer
briefli
raw
read
sampl
map
human
genom
use
sort
convert
sam
format
use
samtool
assembl
transcriptom
use
cufflink
cuffmerg
use
combin
transcript
annot
individu
sampl
singl
refer
transcriptom
cuffquant
use
obtain
persampl
read
count
cuffdiff
use
conduct
differenti
express
analysi
program
run
use
recommend
paramet
import
note
refer
gtf
file
provid
cuffmerg
first
edit
use
custom
python
script
exclud
line
contain
featur
exoncd
contig
chromosom
x
offici
gene
id
transcript
differenti
modul
follow
hpai
infect
without
apocynin
treatment
compil
six
target
list
pairwis
comparison
nd
vs
hd
nd
vs
hd
nd
vs
ha
nd
vs
ha
hd
vs
ha
hd
vs
ha
statist
signific
differenti
express
transcript
defin
chang
benjaminihochberg
adjust
p
valu
background
list
gene
compil
retriev
gene
id
identifi
present
hiseq
analysi
fpkm
biolog
process
go
enrich
perform
use
gorilla
compar
unrank
background
target
redund
go
term
remov
use
target
list
also
subject
kegg
pathway
analysi
use
basic
kegg
pathway
david
bioinformat
resourc
function
annot
mrna
concentr
gene
interest
assess
analyz
use
qrtpcr
perform
duplic
previous
briefli
total
rna
extract
influenzainfect
cell
cdna
prepar
use
iii
firststrand
synthesi
supermix
invitrogen
gene
express
variou
cytokin
assess
use
taqman
gene
express
assay
appli
biosystem
commerci
taqman
primer
probe
except
influenza
matrix
gene
forward
primer
revers
primer
probe
specif
tabl
design
estim
express
atii
cell
use
itaq
univers
sybr
green
supermix
biorad
accord
manufactur
instruct
absenc
nonspecif
amplif
confirm
agaros
gel
electrophoresi
qrtpcr
product
data
shown
gene
express
normal
mrna
use
method
express
level
determin
rel
uninfect
cell
control
assay
perform
duplic
use
appli
steponeplustm
realtim
pcr
system
protein
express
determin
use
western
blot
analysi
previous
protein
concentr
cell
lysat
determin
use
protein
quantit
kit
molecular
probestm
invitrogen
equal
amount
protein
load
nupag
bistri
gel
invitrogen
resolv
sdspage
transfer
pvdf
membran
biorad
membran
probe
rabbit
antihuman
monoclon
antibodi
abcam
follow
goat
antirabbit
hrpconjug
secondari
antibodi
invitrogen
protein
visual
incub
membran
pierc
enhanc
chemiluminesc
ecl
plu
western
blot
substrat
thermo
scientif
follow
detect
biorad
mp
imag
system
ecl
ge
healthcar
use
load
control
membran
strip
strip
buffer
wv
glycin
wv
sd
vv
ph
reprob
hrpconjug
rabbit
monoclon
antibodi
cell
signal
case
two
sdspage
perform
simultan
equal
amount
protein
load
onto
gel
analysi
protein
express
sampl
respect
protein
band
densiti
quantifi
use
fiji
softwar
version
protein
band
densiti
normal
express
fold
chang
compar
control
atii
cell
grown
confluenc
plate
transfect
small
interf
rna
sirna
target
human
gene
select
predesign
sirna
sirna
control
sineg
select
neg
control
sirna
use
lipofetamin
thermofish
scientif
accord
manufactur
instruct
transfect
silenc
effici
evalu
hour
western
blot
analysi
protein
express
qrtpcr
analysi
variant
parallel
experi
viru
replic
cytokinechemokin
product
analyz
sinegtransfect
cell
infect
viru
moi
hpi
differ
two
experiment
group
evalu
use
student
unpair
twotail
test
foldchang
differ
mrna
express
qrtpcr
three
experiment
group
evalu
use
oneway
analysi
varianc
anova
follow
bonferroni
multiplecomparison
test
differ
consid
signific
p
valu
data
shown
mean
standard
error
mean
sem
three
four
individu
experi
statist
analys
perform
use
graphpad
prism
window
